Progyny

Progyny

PGNY
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $185M

Market Cap: $1.8BFounded: 2008Employees: 800+HQ: New York, United States

Overview

Progyny is a mission-driven company focused on removing financial, clinical, and emotional barriers to family building and women's healthcare. It has achieved significant scale, serving over 600 employer clients with a network of more than 1,000 credentialed providers, and is recognized for delivering superior clinical outcomes and cost predictability. Its strategy centers on expanding its data-driven, integrated benefits model from large self-insured employers into the fully insured market, broadening access and solidifying its position as a category leader.

Fertility & InfertilityWomen's HealthMaternal HealthMenopause

Technology Platform

A proprietary integrated platform combining member-facing digital tools, care advocate workflow systems, and data analytics to manage the entire benefits journey, coordinate care, and drive evidence-based clinical pathways.

Funding History

4
Total raised:$185M
IPO$100M
Series C$45M
Series B$25M
Series A$15M

Opportunities

Expansion into the fully insured employer market represents a massive new channel for growth.
Furthermore, broadening its service offerings to cover the full women's health continuum (preconception to menopause) increases lifetime member value and deepens client stickiness within a large, underpenetrated market.

Risk Factors

The regulatory environment for reproductive health is volatile and poses a significant risk.
Economic downturns could pressure employers to cut 'non-essential' benefits, and increasing competition from both health plans and specialized rivals threatens market share and margins.

Competitive Landscape

Progyny competes with traditional health plans (which offer limited fertility benefits) and other fertility benefit managers. It differentiates through its proprietary, actively managed provider network, data-driven clinical pathways, high-touch care advocacy, and comprehensive coverage spanning fertility, pregnancy, and menopause.

Company Timeline

2008Founded

Founded in New York, United States

2016Series B

Series B: $25.0M

2018Series C

Series C: $45.0M

2019IPO

IPO — $100.0M